RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > In Focus: Clinical Trials

In Focus: Clinical Trials

Posted 01 June 2009 | By

The demand to develop drugs, devices and treatment regimens faster and at lower cost has exerted enormous pressure on drug development, particularly over the past 10 years. Financial costs have driven this business in extraordinary and sometimes unforeseen ways. Global outsourcing is one area that has received significant attention. This issue examines globalization as it relates to cost containment of clinical trials. We also look at other cost themes: opportunity, patient (safety), regulatory and reimbursement.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.